Advanced search
Publication Cover
OncoImmunology Volume 5, 2016 - Issue 5
Submit an article Journal homepage
1,793
Views
21
CrossRef citations to date
0
Altmetric
Original Research

The multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant glioma

Sara PessinaUnit of Molecular Neuro-Oncology, Milan, ItalyView further author information
,
Gabriele CantiniUnit of Molecular Neuro-Oncology, Milan, ItalyView further author information
,
Dimos KapetisUnit of Bioinformatics, Fondazione I.R.C.C.S. Istituto Neurologico C Besta, Milan, ItalyView further author information
,
Emanuela CazzatoUnit of Molecular Neuro-Oncology, Milan, ItalyView further author information
,
Natalia Di IanniUnit of Molecular Neuro-Oncology, Milan, ItalyView further author information
,
Gaetano FinocchiaroUnit of Molecular Neuro-Oncology, Milan, ItalyView further author information
&
Serena PellegattaUnit of Molecular Neuro-Oncology, Milan, ItalyCorrespondence[email protected]
View further author information
 show all
Article: e1108513 | Received 26 Jun 2015, Accepted 10 Oct 2015, Published online: 19 Apr 2016

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Alice Giotta Lucifero & Sabino Luzzi. (2022) Emerging immune-based technologies for high-grade gliomas. Expert Review of Anticancer Therapy 22:9, pages 957-980.
Read now
Adam M. Swartz, Steven H. Shen, Miguel A. Salgado, Kendra L. Congdon & Luis Sanchez-Perez. (2018) Promising vaccines for treating glioblastoma. Expert Opinion on Biological Therapy 18:11, pages 1159-1170.
Read now
Serena Pellegatta, Marica Eoli, Valeria Cuccarini, Elena Anghileri, Bianca Pollo, Sara Pessina, Simona Frigerio, Maura Servida, Lucia Cuppini, Carlo Antozzi, Stefania Cuzzubbo, Cristina Corbetta, Rosina Paterra, Francesco Acerbi, Paolo Ferroli, Francesco DiMeco, Laura Fariselli, Eugenio A. Parati, Maria Grazia Bruzzone & Gaetano Finocchiaro. (2018) Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomide. OncoImmunology 7:4.
Read now
Guranda Chitadze, Charlotte Flüh, Elgar Susanne Quabius, Sandra Freitag-Wolf, Christian Peters, Marcus Lettau, Jaydeep Bhat, Daniela Wesch, Hans-Heinrich Oberg, Stefanie Luecke, Ottmar Janssen, Michael Synowitz, Janka Held-Feindt & Dieter Kabelitz. (2017) In-depth immunophenotyping of patients with glioblastoma multiforme: Impact of steroid treatment. OncoImmunology 6:11.
Read now

Articles from other publishers (17)

Edoardo Agosti, Pier Paolo Panciani, Marco Zeppieri, Lucio De Maria, Francesco Pasqualetti, Alessandro Tel, Luca Zanin, Marco Maria Fontanella & Tamara Ius. (2023) Tumor Microenvironment and Glioblastoma Cell Interplay as Promoters of Therapeutic Resistance. Biology 12:5, pages 736.
Crossref
Eduardo Ruiz-López, Ivana Jovčevska, Ruth González-Gómez, Héctor Tejero, Fátima Al-Shahrour, Serge Muyldermans & Alberto J. Schuhmacher. (2022) Nanobodies targeting ABCC3 for immunotargeted applications in glioblastoma. Scientific Reports 12:1.
Crossref
Maria Beatrice Morelli, Massimo Nabissi, Consuelo Amantini, Federica Maggi, Lucia Ricci-Vitiani, Roberto Pallini & Giorgio Santoni. (2022) TRPML2 Mucolipin Channels Drive the Response of Glioma Stem Cells to Temozolomide and Affect the Overall Survival in Glioblastoma Patients. International Journal of Molecular Sciences 23:23, pages 15356.
Crossref
Yudong Cao, Hecheng Zhu, Quan Chen, Hailong Huang, Dongcheng Xie, Xuewen Li, Xingjun Jiang, Caiping Ren & Jiahui Peng. (2022) Integrated analysis of inflammatory response subtype-related signature to predict clinical outcomes, immune status and drug targets in lower-grade glioma. Frontiers in Pharmacology 13.
Crossref
Natalia Di Ianni, Martina Maffezzini, Marica Eoli & Serena Pellegatta. (2021) Revisiting the Immunological Aspects of Temozolomide Considering the Genetic Landscape and the Immune Microenvironment Composition of Glioblastoma. Frontiers in Oncology 11.
Crossref
Mohammed Ahmed, Maite Verreault, Xavier Declèves & Ahmed Idbaih. 2021. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies 243 261 .
Huiling Qu, Xiaofu Song, Zhuyin Song, Xin Jiang, Xin Gao, Lijuan Bai, Jiao Wu, Li Na & Zhicheng Yao. (2020) Berberine reduces temozolomide resistance by inducing autophagy via the ERK1/2 signaling pathway in glioblastoma. Cancer Cell International 20:1.
Crossref
Soohwan Lee, Hie Bum Suh, Su Ji Choi, Junho Kang, Ji Wan Kang, Eun Jung Kwon, Hak-Jun Kim, Yun Hak Kim & Kihyuk Shin. (2020) Identification of prognostic mRNAs in metastatic cutaneous melanoma. Melanoma Research 30:6, pages 543-547.
Crossref
Wen Lvu, Xu Fei, Cheng Chen & Bo Zhang. (2020) In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma . Bioscience Reports 40:8.
Crossref
Vivek Singh Tomar, Vikas Patil & Kumaravel Somasundaram. (2019) Temozolomide induces activation of Wnt/β-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biology and Toxicology 36:3, pages 273-278.
Crossref
Dipongkor Saha, Samuel D Rabkin & Robert L Martuza. (2020) Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma. Journal for ImmunoTherapy of Cancer 8:1, pages e000345.
Crossref
Zelin Sun, Xiaoyuan Qi & Yan Zhang. (2020) Bioinformatics Analysis of the Expression of ATP binding cassette subfamily C member 3 (ABCC3) in Human Glioma. Open Medicine 15:1, pages 107-113.
Crossref
Alberto Lazarowski. 2020. Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy. Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy 149 195 .
Pellegatta, Ianni, Pessina, Paterra, Anghileri, Eoli & Finocchiaro. (2019) ABCC3 Expressed by CD56dim CD16+ NK Cells Predicts Response in Glioblastoma Patients Treated with Combined Chemotherapy and Dendritic Cell Immunotherapy. International Journal of Molecular Sciences 20:23, pages 5886.
Crossref
Fengfei Wang, Zheng Zheng, Jitian Guan, Dan Qi, Shuang Zhou, Xin Shen, Fushun Wang, David Wenkert, Batool Kirmani, Touradj Solouki, Ekokobe Fonkem, Eric T. Wong, Jason H. Huang & Erxi Wu. (2018) Identification of a panel of genes as a prognostic biomarker for glioblastoma. EBioMedicine 37, pages 68-77.
Crossref
Adrienne C. Scheck. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy 87 104 .
Diandong Hou, Decheng Wang, Xiande Ma, Wenna Chen, Shengnan Guo & Hongquan Guan. (2017) Effects of total flavonoids of sea buckthorn ( Hippophae rhamnoides L.) on cytotoxicity of NK92-MI cells . International Journal of Immunopathology and Pharmacology 30:4, pages 353-361.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.